Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas

被引:0
|
作者
M T Rahman
K Nakayama
M Rahman
H Katagiri
A Katagiri
T Ishibashi
M Ishikawa
K Iida
N Nakayama
Y Otsuki
S Nakayama
K Miyazaki
机构
[1] Shimane University School of Medicine,Departments of Obstetrics and Gynecology
[2] Shimane University School of Medicine,Department of Biocehmistory
[3] Seirei Hamamatsu General Hospital,Department of Pathology
[4] Seirei Hamamatsu General Hospital,Department of Obstetrics and Gynecology
来源
British Journal of Cancer | 2012年 / 107卷
关键词
ovarian clear cell carcinoma; fatty acid synthase; survival; NAC1; C75;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:300 / 307
页数:7
相关论文
共 50 条
  • [21] Overexpression of fatty acid synthase (FAS) in recurrent, chemoresistant ovarian serous carcinomas and the potential therapeutic role of selective FAS inhibitors
    Ueda, S. M.
    Li, Q.
    Wang, T.
    Kuhajda, F.
    Davidson, B.
    Shih, I.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S16 - S16
  • [22] Expression of Podoplanin in Epithelial Ovarian Carcinomas and its Potential as a Marker for Clear Cell Adenocarcinoma
    Oe, Shuko
    Hasegawa, Kiyoshi
    Nagase, Sayaka
    Kato, Rina
    Torii, Yutaka
    Udagawa, Yasuhiro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (05) : 405 - 410
  • [23] A NEW MARKER OF POOR OUTCOME AND POTENTIAL THERAPEUTIC TARGET IN OVARIAN CLEAR CELL CARCINOMA
    Hooper, J.
    He, Y.
    Wu, A.
    Harrington, B.
    Davies, C.
    Wallace, S.
    Gilks, B.
    Perrin, L.
    Armes, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 958 - 959
  • [24] MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
    Makii, Chinami
    Oda, Katsutoshi
    Ikeda, Yuji
    Sone, Kenbun
    Hasegawa, Kosei
    Uehara, Yuriko
    Nishijima, Akira
    Asada, Kayo
    Koso, Takahiro
    Fukuda, Tomohiko
    Inaba, Kanako
    Oki, Shinya
    Machino, Hidenori
    Kojima, Machiko
    Kashiyama, Tomoko
    Mori-Uchino, Mayuyo
    Arimoto, Takahide
    Wada-Hiraike, Osamu
    Kawana, Kei
    Yano, Tetsu
    Fujiwara, Keiichi
    Aburatani, Hiroyuki
    Osuga, Yutaka
    Fujii, Tomoyuki
    ONCOTARGET, 2016, 7 (46) : 75328 - 75338
  • [25] ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
    Sato, Emi
    Nakayama, Kentaro
    Razia, Sultana
    Nakamura, Kohei
    Ishikawa, Masako
    Minamoto, Toshiko
    Ishibashi, Tomoka
    Yamashita, Hitomi
    Iida, Kouji
    Kyo, Satoru
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [26] NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma
    Ishikawa, Masako
    Nakayama, Kentaro
    Yeasmin, Shamima
    Katagiri, Atsuko
    Iida, Kouji
    Nakayama, Naomi
    Miyazaki, Kohji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (05) : 1097 - 1103
  • [27] CRBP-1 Expression in Ovarian Cancer: A Potential Therapeutic Target
    Doldo, Elena
    Costanza, Gaetana
    Ferlosio, Amedeo
    Passeri, Daniela
    Bernardini, Sergio
    Scioli, Maria Giovanna
    Mazzaglia, Donatella
    Agostinelli, Sara
    Del Bufalo, Donatella
    Czernobilsky, Bernard
    Orlandi, Augusto
    ANTICANCER RESEARCH, 2014, 34 (07) : 3303 - 3312
  • [28] Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target
    Tsang, Tsun Yee
    Wei, Wei
    Itamochi, Hiroaki
    Tambouret, Rosemary
    Birrer, Michael J.
    ONCOTARGET, 2017, 8 (57) : 96482 - 96495
  • [29] Fatty acid synthase is a potential therapeutic target in Micro-satellite-instable colorectal cancers
    Al-Kuraya, K.
    EJC SUPPLEMENTS, 2008, 6 (12): : 115 - 115
  • [30] Fatty acid synthase inhibition as a potential therapeutic target in triple-negative breast cancer
    Giro, A.
    Blancafort, A.
    Oliveras, G.
    Perez-Bueno, F.
    Dorca, J.
    Vinas, G.
    Puig, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S180 - S180